Dizal (SSE:688192), a biopharmaceutical company committed to developing novel medicines for the treatment of cancer and ...

Two major contributors to reduced health-related quality of life (HRQoL) in patients with chronic lymphocytic leukemia (CLL) and lymphoma are muscle weakness and fatigue, according to a study ...

Statin therapy potentially reduces cancer mortality risk by 60%, a new study indicates. LONDON, April 24: ...

Studies have shown that using statin drugs used to treat hyperlipidemia as a combination therapy can reduce the risk of ...

Now, new research suggests that they do more than just benefiting your heart, they also mitigate the risk of cancer. Recently ...

Seven oral presentations will unveil novel immunotherapy insights, including IBI363, at one of oncology’s biggest global ...